These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37000415)

  • 1. Long-term effectiveness of add-on perampanel in patients with Lennox-Gastaut syndrome: A multicenter retrospective study.
    Matricardi S; Cesaroni E; Bonanni P; Foschi N; D Aniello A; Di Gennaro G; Striano P; Cappanera S; Siliquini S; Freri E; Ragona F; Granata T; Deleo F; Villani F; Russo A; Messana T; Siri L; Bagnasco I; Vignoli A; Operto FF; Orsini A; Bonuccelli A; Papa A; Peruzzi C; Liguori C; Verrotti A; Chiarelli F; Marini C; Lattanzi S
    Epilepsia; 2023 Jun; 64(6):e98-e104. PubMed ID: 37000415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
    Alonso-Singer P; Aguilar-Amat Prior MJ; Oliva-Navarro J; Massot-Tarrús A; Giráldez BG; Bermejo P; DeToledo-Heras M; Aledo-Serrano Á; Martínez-Cayuelas E; Tirado-Requero P; Velázquez-Fragua R; López-Sobrino G; Ojeda J
    Epilepsy Behav; 2022 Sep; 134():108836. PubMed ID: 35870432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of perampanel in children and adolescents with Lennox-Gastaut Syndrome.
    Auvin S; Dozieres B; Ilea A; Delanoë C
    Epilepsy Behav; 2017 Sep; 74():59-63. PubMed ID: 28715780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
    Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, uncontrolled retrospective study of perampanel in adults with Lennox-Gastaut syndrome.
    Crespel A; Tang NPL; Macorig G; Gelisse P; Genton P
    Seizure; 2020 Feb; 75():66-69. PubMed ID: 31877501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-seizure medications for Lennox-Gastaut syndrome.
    Brigo F; Jones K; Eltze C; Matricardi S
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
    Nikanorova M; Brandt C; Auvin S; McMurray R
    Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
    Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
    Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
    Isojarvi J; Gidal BE; Chung S; Wechsler RT
    Epilepsy Behav; 2018 Jan; 78():149-154. PubMed ID: 29202277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy.
    Villanueva V; García-Ron A; Smeyers P; Arias E; Soto V; García-Peñas JJ; González-Alguacil E; Sayas D; Serrano-Castro P; Garces M; Hampel K; Tomás M; Lara J; de Toledo M; Barceló I; Aledo-Serrano A; Gil-Nagel A; Iacampo L; Falip M; Saiz-Diaz RA; Gómez-Ibañez A; Sopelana D; Sanchez-Larsen A; López-González FJ
    Epilepsy Behav; 2022 Dec; 137(Pt A):108958. PubMed ID: 36327646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
    Kim SH; Kang HC; Lee JS; Kim HD
    Brain Dev; 2018 Nov; 40(10):897-903. PubMed ID: 30166208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome.
    Lagae L; Schoonjans AS; Gammaitoni AR; Galer BS; Ceulemans B
    Epilepsia; 2018 Oct; 59(10):1881-1888. PubMed ID: 30146701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
    Knupp KG; Scheffer IE; Ceulemans B; Sullivan J; Nickels KC; Lagae L; Guerrini R; Zuberi SM; Nabbout R; Riney K; Agarwal A; Lock M; Dai D; Farfel GM; Galer BS; Gammaitoni AR; Polega S; Davis R; Gil-Nagel A
    Epilepsia; 2023 Jan; 64(1):139-151. PubMed ID: 36196777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome.
    Kim HJ; Kim SH; Kang HC; Lee JS; Chung HJ; Kim HD
    Pediatr Neurol; 2014 Oct; 51(4):527-31. PubMed ID: 25266616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulthiame add-on therapy in children with Lennox-Gastaut syndrome: A study of 44 patients.
    Caraballo RH; Flesler S; Reyes Valenzuela G; Fortini S; Chacón S; Ross L; Noli D
    Seizure; 2018 Nov; 62():55-58. PubMed ID: 30286409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome.
    Kessler SK; McCarthy A; Cnaan A; Dlugos DJ
    Epilepsy Res; 2015 May; 112():18-26. PubMed ID: 25847334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA).
    Hahn CD; Jiang Y; Villanueva V; Zolnowska M; Arkilo D; Hsiao S; Asgharnejad M; Dlugos D
    Epilepsia; 2022 Oct; 63(10):2671-2683. PubMed ID: 35841234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is adjunctive Cannabidiol effective in controlling seizures for adult patients with Lennox-Gastaut Syndrome? - A single centre long term follow up study.
    Elbadri M; Bose S; Elkider M; Hayton T; McCorry D; Sumangala S; Wysota B; Samarasekera S
    Epilepsy Behav; 2024 Aug; 157():109904. PubMed ID: 38908033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.